EDSA
Price
$4.23
Change
-$0.43 (-9.23%)
Updated
Sep 11 closing price
Capitalization
40.97M
Intraday BUY SELL Signals
MBRX
Price
$0.71
Change
-$0.12 (-14.46%)
Updated
Sep 11 closing price
Capitalization
14.15M
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDSA vs MBRX

EDSA vs MBRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EDSA vs. MBRX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDSA is a Hold and MBRX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDSA($41M) has a higher market cap than MBRX($14.2M). EDSA YTD gains are higher at: 197.887 vs. MBRX (-78.399). EDSA has higher annual earnings (EBITDA): -14M vs. MBRX (-28.83M). EDSA has more cash in the bank: 10.3M vs. MBRX (7.26M). EDSA has less debt than MBRX: EDSA (0) vs MBRX (292K). EDSA (0) and MBRX (0) have equivalent revenues.
EDSAMBRXEDSA / MBRX
Capitalization41M14.2M289%
EBITDA-14M-28.83M49%
Gain YTD197.887-78.399-252%
P/E RatioN/A0.05-
Revenue00-
Total Cash10.3M7.26M142%
Total Debt0292K-
FUNDAMENTALS RATINGS
EDSA vs MBRX: Fundamental Ratings
EDSA
MBRX
OUTLOOK RATING
1..100
436
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5957
P/E GROWTH RATING
1..100
10023
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBRX's Valuation (14) in the Pharmaceuticals Major industry is significantly better than the same rating for EDSA (100) in the null industry. This means that MBRX’s stock grew significantly faster than EDSA’s over the last 12 months.

MBRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as EDSA (100) in the null industry. This means that MBRX’s stock grew similarly to EDSA’s over the last 12 months.

MBRX's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as EDSA (100) in the null industry. This means that MBRX’s stock grew similarly to EDSA’s over the last 12 months.

MBRX's Price Growth Rating (57) in the Pharmaceuticals Major industry is in the same range as EDSA (59) in the null industry. This means that MBRX’s stock grew similarly to EDSA’s over the last 12 months.

MBRX's P/E Growth Rating (23) in the Pharmaceuticals Major industry is significantly better than the same rating for EDSA (100) in the null industry. This means that MBRX’s stock grew significantly faster than EDSA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDSAMBRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
67%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (EDSA: $4.23 vs. MBRX: $0.71)
Brand notoriety: EDSA and MBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDSA: 41% vs. MBRX: 178%
Market capitalization -- EDSA: $40.97M vs. MBRX: $14.15M
EDSA [@Biotechnology] is valued at $40.97M. MBRX’s [@Biotechnology] market capitalization is $14.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDSA’s FA Score shows that 0 FA rating(s) are green while MBRX’s FA Score has 2 green FA rating(s).

  • EDSA’s FA Score: 0 green, 5 red.
  • MBRX’s FA Score: 2 green, 3 red.
According to our system of comparison, MBRX is a better buy in the long-term than EDSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDSA’s TA Score shows that 5 TA indicator(s) are bullish while MBRX’s TA Score has 5 bullish TA indicator(s).

  • EDSA’s TA Score: 5 bullish, 3 bearish.
  • MBRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both EDSA and MBRX are a good buy in the short-term.

Price Growth

EDSA (@Biotechnology) experienced а -10.57% price change this week, while MBRX (@Biotechnology) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

MBRX is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
EDSA
Daily Signal:
Gain/Loss:
MBRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALAR1.920.14
+7.87%
Alarum Technologies Ltd
DAL79.911.67
+2.13%
Delta Air Lines
CSR58.290.60
+1.04%
Centerspace
HRI140.96-1.08
-0.76%
Herc Holdings
AIIO1.68-0.11
-6.15%
Robo.ai Inc.

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with KPTI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then KPTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-13.85%
KPTI - MBRX
51%
Loosely correlated
-0.62%
EDSA - MBRX
38%
Loosely correlated
-9.23%
AMRN - MBRX
32%
Poorly correlated
-1.71%
UNCY - MBRX
31%
Poorly correlated
-0.38%
AXON - MBRX
29%
Poorly correlated
+0.10%
More